» Articles » PMID: 20629714

HLA-DRB1: Genetic Susceptibility and Disability Progression in a Spanish Multiple Sclerosis Population

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2010 Jul 16
PMID 20629714
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: The association of HLA-DRB1*15 with susceptibility to multiple sclerosis (MS) has been consistently reported although its effect on the clinical phenotype is still controversial. The objectives of this study are to investigate the influence of the HLA-DRB1 alleles on the genetic susceptibility to MS and to study their impact on disability progression in a Spanish population.

Methods: HLA-DRB1 typing was performed by PCR-SSP in 380 patients with sporadic MS and 1088 unrelated healthy controls. Allelic frequencies were compared between groups. We studied the correlation between the different alleles and the progression of MS.

Results: The HLA-DRB1*15 allele in patients with MS had a statistically significant higher frequency when compared with controls (18.9% in patients vs. 10.1% in controls, Odds ratio (OR)=2.07, 95% CI=1.64-2.60, P<0.001). In the univariate analysis, the DRB1*01 and DRB1*04 alleles were associated with a worse prognosis when considering the time to reach an EDSS of 6, whereas the DRB1*03 was correlated with a better outcome. In the multivariate analysis, the alleles*01 and *04 were demonstrated to be independent factors to have a worse prognosis.

Conclusions: HLA-DRB1*15 is associated with MS when comparing patients with unrelated healthy controls in a Spanish population. The HLA-DRB1*01 and HLA-DRB1*04 alleles are related to a worse prognosis when considering the time taken to reach severe disability.

Citing Articles

The elusive nature of the oligoclonal bands in multiple sclerosis.

Kennedy P, George W, Yu X J Neurol. 2023; 271(1):116-124.

PMID: 37945762 DOI: 10.1007/s00415-023-12081-7.


Genetic Variant HLA-DRB1*0403 and Therapeutic Response to Disease-Modifying Therapies in Multiple Sclerosis: A Case-Control Study.

Gomez-Gaitan E, Garcia-Ortega Y, Saldana-Cruz A, Contreras-Haro B, Gamez-Nava J, Perez-Guerrero E Int J Mol Sci. 2023; 24(19).

PMID: 37834042 PMC: 10572793. DOI: 10.3390/ijms241914594.


Association of infections with multiple sclerosis in Gulf Cooperation Council countries: a review.

Al Wutayd O J Int Med Res. 2019; 48(4):300060519884151.

PMID: 31880177 PMC: 7607054. DOI: 10.1177/0300060519884151.


Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.

Mackie S, Taylor J, Haroon-Rashid L, Martin S, Dasgupta B, Gough A Arthritis Res Ther. 2015; 17:195.

PMID: 26223536 PMC: 4520081. DOI: 10.1186/s13075-015-0692-4.


Sex and gender issues in multiple sclerosis.

Harbo H, Gold R, Tintore M Ther Adv Neurol Disord. 2013; 6(4):237-48.

PMID: 23858327 PMC: 3707353. DOI: 10.1177/1756285613488434.